In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Objectives: Antimicrobial resistance, including multidrug-resistance (MDR), is increasing, especially among Gram-negative bacilli. New agents are needed to treat infections caused by these pathogens. This report assessed the activity of imipenem/relebactam against Gram-negative bacilli from intraabd...

Full description

Bibliographic Details
Main Authors: James A. Karlowsky, Sibylle H. Lob, Krystyna M. Kazmierczak, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Imipenem/relebactam
Gram-negative bacilli
United States
Study for Monitoring Antimicrobial Resistance Trends (SMART)
Intraabdominal infection
Urinary tract infection
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716519302905

Internet

http://www.sciencedirect.com/science/article/pii/S2213716519302905

Similar Items